Soleno Therapeutics, Inc. Common Stock
Symbol: SLNO (NASDAQ)
60.59
▼ (-13.70%) -9.620
Company Description:
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Key Stats
- Today's Open: $70.57
- Today's High: $71.175
- Today's Low: $51.365
- Today's Volume: 8.26M
- Yesterday Close: $70.21
- Yesterday High: $72.99
- Yesterday Low: $68.11
- Yesterday Volume: 971.39K
- Last Min Volume: 1
- Last Min High: $60.59
- Last Min Low: $60.59
- Last Min VWAP: $60.59
Company Profile
- Name: Soleno Therapeutics, Inc. Common Stock
- Website: https://www.soleno.life
- Listed Date: 2014-11-13
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001484565
- SIC Code: 3845
- SIC description: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
- Market Cap: $3.84B
- Round Lot: 100
- Outstanding Shares: 53.15M
- Asset Type: CS
RECENT FILINGS FOR SLNO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 8-K | View |
| 2025-08-18 | 8-K | View |
| 2025-08-15 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-07 | SCHEDULE 13G/A | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-08-06 | SCHEDULE 13G | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-11 | 424B5 | View |
| 2025-07-11 | 8-K | View |
| 2025-07-10 | 8-K | View |
| 2025-07-10 | 424B5 | View |
| 2025-07-03 | 4 | View |
| 2025-07-01 | 144 | View |
Latest News on SLNO